Investment AB Latour (publ)
Investment AB Latour (publ) (IVTBF) Financial Performance & Income Statement Overview
Analyze Investment AB Latour (publ) (IVTBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Investment AB Latour (publ) (IVTBF) Income Statement & Financial Overview
Analyze Investment AB Latour (publ)’s IVTBF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $6.88B | $7.01B | $6.23B | $6.52B |
| Cost of Revenue | $4.12B | $4.30B | $3.77B | $3.92B |
| Gross Profit | $2.77B | $2.71B | $2.46B | $2.60B |
| Gross Profit Ratio | $0.40 | $0.39 | $0.39 | $0.40 |
| R&D Expenses | $208.00M | $198.00M | $174.00M | $200.00M |
| SG&A Expenses | $1.71B | $1.64B | $1.41B | $1.52B |
| Operating Expenses | $1.94B | $1.77B | $1.56B | $1.72B |
| Total Costs & Expenses | $6.05B | $6.07B | $5.33B | $5.64B |
| Interest Income | $150.00M | $121.00M | $0.00 | $4.00M |
| Interest Expense | $572.00M | $101.00M | $185.00M | $98.00M |
| Depreciation & Amortization | $0.00 | $0.00 | $597.00M | $177.00M |
| EBITDA | $1.52B | $1.79B | $1.49B | $1.10B |
| EBITDA Ratio | $0.22 | $0.26 | $0.24 | $0.17 |
| Operating Income | $829.00M | $944.00M | $895.00M | $879.00M |
| Operating Income Ratio | $0.12 | $0.13 | $0.14 | $0.13 |
| Other Income/Expenses (Net) | $117.00M | $746.00M | $412.00M | -$103.00M |
| Income Before Tax | $946.00M | $1.69B | $1.31B | $829.00M |
| Income Before Tax Ratio | $0.14 | $0.24 | $0.21 | $0.13 |
| Income Tax Expense | $134.00M | $226.00M | $222.00M | $197.00M |
| Net Income | $799.00M | $1.46B | $1.08B | $1.65B |
| Net Income Ratio | $0.12 | $0.21 | $0.17 | $0.25 |
| EPS | $1.25 | $2.29 | $1.68 | $2.57 |
| Diluted EPS | $1.25 | $2.28 | $1.68 | $2.57 |
| Weighted Avg Shares Outstanding | $639.32M | $639.32M | $639.39M | $639.33M |
| Weighted Avg Shares Outstanding (Diluted) | $640.96M | $640.96M | $640.86M | $641.13M |
The company's financials show resilient growth, with revenue advancing from $6.52B in Q2 2024 to $6.88B in Q1 2025. Gross profit remained healthy with margins at 40% in Q1 2025 compared to 40% in Q2 2024. Operating income hit $829.00M last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.52B. Net income dropped to $799.00M, while earnings per share reached $1.25. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan